BiotechTube

Placebo + Prednisolone

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Insulin Resistance

Conditions

Insulin Resistance, Hyperglycemia, Glucose Intolerance

Trial Timeline

May 1, 2006 → Mar 1, 2008

NCT ID
NCT00971724

About Placebo + Prednisolone

Placebo + Prednisolone is a pre-clinical stage product being developed by Merck for Insulin Resistance. The current trial status is completed. This product is registered under clinical trial identifier NCT00971724. Target conditions include Insulin Resistance, Hyperglycemia, Glucose Intolerance.

What happened to similar drugs?

7 of 20 similar drugs in Insulin Resistance were approved

Approved (7) Terminated (1) Active (13)
🔄AC2993 + AC2993 + Placebo + PlaceboAstraZenecaPhase 3
🔄Dapagliflozin 10 mg + Placebo tabletAstraZenecaPhase 3
✅SaxagliptinAstraZenecaApproved
🔄AC2993 + AC2993 + Placebo + PlaceboAstraZenecaPhase 3
🔄sitagliptin + Comparator: glimepiride + open-label metforminMerckPhase 3
✅sitagliptinMerckApproved
🔄sitagliptin phosphateMerckPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00971724Pre-clinicalCompleted

Competing Products

20 competing products in Insulin Resistance

See all competitors
ProductCompanyStageHype Score
naveglitazarEli LillyPhase 2
35
AC2993 + AC2993 + Placebo + PlaceboAstraZenecaPhase 3
40
Dapagliflozin 10 mg + Placebo tabletAstraZenecaPhase 3
40
Placebo 0.01 mL + Placebo 0.02 mL + Placebo 0.03 mL + Placebo 0.04 mL + AC2993 2.5 mcg + AC2993 5.0 mcg + AC2993 7.5 mcg + AC2993 10.0 mcgAstraZenecaPhase 2
35
Atropine + Physostigmine + Placebo SodiumAstraZenecaPhase 1
29
SaxagliptinAstraZenecaApproved
43
AC2993 + AC2993 + Placebo + PlaceboAstraZenecaPhase 3
40
Pramlintide acetateAstraZenecaPhase 2
35
sitagliptin + Comparator: glimepiride + open-label metforminMerckPhase 3
40
sitagliptinMerckApproved
35
sitagliptin phosphateMerckPhase 3
40
MK-1006 + PlaceboMerckPhase 1
29
Comparator: Placebo + Sitagliptin + VogliboseMerckPhase 3
40
sitagliptin phosphate + Comparator: metformin + Comparator: metformin + Comparator: Antidiabetic Standard of CareMerckPhase 3
40
Placebo + MK-0941MerckPhase 1
29
Comparator: exenatide + Comparator: exenatide + Comparator: PlaceboMerckPhase 1
29
simvastatin/ezetimibe + atorvastatin 20mgMerckApproved
39
sitagliptin phosphate + Comparator: Placebo + Comparator: SitagliptinMerckPhase 2
35
sitagliptin phosphateMerckPhase 1
29
sitagliptin phosphate + Comparator: vogliboseMerckPhase 3
40